Filing Details

Accession Number:
0001209191-18-041386
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 21:05:49
Reporting Period:
2018-07-02
Accepted Time:
2018-07-03 21:05:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
818033 Heron Therapeutics Inc. HRTX Pharmaceutical Preparations (2834) 942875566
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202094 Kimberly Manhard 4242 Campus Point Court
Suite 200
San Diego CA 92121
Executive Vp, Drug Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-02 6,000 $13.00 6,000 No 4 M Direct
Common Stock Disposition 2018-07-02 5,900 $37.51 100 No 4 S Direct
Common Stock Disposition 2018-07-02 100 $38.85 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-07-02 6,000 $0.00 6,000 $13.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
88,416 2026-12-21 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018.
  2. The range of sales prices received was $37.70 to $38.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  3. The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016).